Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.

Based on previous experimental and clinical findings of pharmacological conditioning with immune responses, we propose that the JIA patient group is particularly suited to benefit from a pharmacological conditioning design. Moreover, findings from this study may potentially also be promising for other patient groups that endure long-lasting drug therapies.